Gangwon, South Korea

Jee Sun Yun

This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Abtlas Co., Ltd.. Active years: 2018-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jee Sun Yun. Retrieved from https://idiyas.com/inventor/jee-sun-yun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovative Achievements of Inventor Jee Sun Yun

Introduction

Jee Sun Yun is a notable inventor based in Gangwon-do, South Korea, recognized for his significant contributions to the field of protein engineering. With a total of two patents to his name, he has dedicated his work to advancing therapeutic methods through innovative approaches.

Latest Patents

His latest patents include a groundbreaking invention titled "Protein combination-based FV library, and preparation method therefor," which presents a novel method for constructing a functional variable (Fv) antibody library based on protein combinations. This invention not only allows for the individual analysis of protein functions but also facilitates the screening of desired antibodies without the need for a target antigen preparation. This advancement significantly minimizes the number of protein purification processes, thereby reducing costs and time compared to conventional DNA-based libraries.

The second notable patent is the "Method for refining protein including self-cutting cassette and use thereof." This invention involves a self-cleaving fusion protein that includes a target protein alongside specific sequences and tags necessary for function. It details a refined method for purifying target proteins and preparing therapeutic antibody-drug conjugates using the purification method, enhancing the efficiency and effectiveness of therapeutic applications.

Career Highlights

Jee Sun Yun is currently associated with Abtlas Co., Ltd., where he continues to innovate within the biotechnology sector. His work demonstrates a strong commitment to advancing medical science through novel protein solutions and therapeutic advancements.

Collaborations

Throughout his career, Jee has worked alongside esteemed colleagues, including Byeong Doo Song and Hyo Jung Choi. These collaborations have further strengthened his research efforts and contributed to the success of his innovative projects.

Conclusion

Jee Sun Yun's contributions to the field of protein engineering underscore the importance of innovation in developing new therapeutic strategies. His patents reflect a deep understanding of biochemistry and a commitment to advancing the healthcare industry, promising to influence future research and applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…